Because of Jeff's personal experience with this medical technology, he thinks it can change the world: "it's an amazing new trend in medication driven by innovation that identified cancer. And offered me a battling chance to beat it extremely early prior to it became a potentially deadly problem." Jeff does not simply suggest purchasing this business to capitalize on this pattern.
2 trillion market that will alter the world of medication: "However there's more to this technology than just conserving my life. It's the pointer of the iceberg of a $3. 2 trillion development that I believe will change the way we take a look at medication." By subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff believes it will change the world of medication.
Jeff Brown uses Mirati Therapies as an example, which rose 8,481% in under two years. Other gains included on The Near Future Report's sales page include: Jeff Brown is careful to discuss that past revenues do not guarantee future results.
He does not advise allocating a significant part of your portfolio to these stocks. However, Jeff likewise claims he has actually "visited suppliers and done his own research study on future profits" to validate his recommendations. Based on that analysis, Jeff is confident that a few of his biotech stock picks will increase significantly in the future.
2 Trillion Market that Could Save Millions of Lives? Jeff, like many investors, thinks biotech will be one of the most popular tech trends over the coming years. Biotech is no trick.
Jeff points out precision medication as one example: "the biotech market is expected to grow 86% over the next few years. That is excellent. However listen to this, The accuracy medicine market is expected to grow 152% during that exact same time" Precision medicine is an emerging area of biotech that utilizes exact biological information to determine disease danger.